1Lallemant M,Jourdain G,Le Coeur S,et al.A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1[J].N Engl J Med,2000,343(14):982-991.
2Arbona SI,Melville SK,Hanson C,et al.Mother-to-child transmission of the human immunodeficiency virus in Texas[J].Pediatr Infect Dis J,2001,20(6):602-606.
3Kourtis AP,Bulterys M,Nesheim SR,et al.Understanding the timing of HIV transmission from mother to infant[J].JAMA,2001,285(6):709-712.
4Connor EM,Sperling RS,Gelber R,et al.Reduction of matemal-infant transmission of human immunodefuiency virus type 1 with zidovudine treatment[J].N Engl J Med,1994,311(18):1 173-1 180.
5Blanche S,Tardieu M,Rustin P,et al.Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues[J].Lancet,1999,354(9 184):1 084-1 089.
6Perinatal Safety Review Working Group.Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs[J].J Acquir Immune Defic Syndr,2000,25(3):261-268.
7Shaffer N,Chuachoowong R,Mock PA,et al.Short-course zidovudine for pefinatal HIV-1 transmission in Bangkok.Thailand[J].Lancet,1999,353(9 155):773-780.
8Dabis F,Msellati P,Meda N,et al.6-month efficacy,tolerance,and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'lvoire and Burkina Faso[J].Lancet,1999,353(9 155):786-792.
9Fiscus S,Adimora A,Schoenbach VJ,et al.Trends in HIV counseling,testing and antiretroviral treatment of HIV-infected women and perinatal transmission in North Carolina[J].J Infect Dis,1999,180(1):99-105.
10Wade N,Birkhead GS,Warren BL,et al.Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus[J].N Engl J Med,1998,339(20):1 409-1 414.
